The goal of this project is to isolate inhibitors of apoptosis that can activate autophagy. Apoptosis has been implicated in a wide array of human inflammatory and degenerative diseases. However, after more than 30 years of research, the field failed to deliver a target that can be pharmacologically manipulated to inhibit apoptosis, as direct inhibition of caspases leads to necroptosis. Activating autophagy will support cell survival under stress condition.
Funding
Funding Duration
July 1, 2017 - December 31, 2019
Funding level
Development
People
Principal Investigator
Junying Yuan
PhD
Elizabeth D. Hay Professor of Cell Biology, Harvard Medical School
Co-PI
Slawomir Dziedzic
Ph.D.
Scientist, Checkpoint Immunity Cluster, Sanofi
Jiefei Geng
Senior Scientist, Obsidian Therapeutics
Mingzhi Jin
PhD
Assistant Director, WuXi AppTec
Hong Zhu
BS
Associate in Cell Biology, Harvard Medical School
Intellectual Property
Publications
Patents
WO2021257697
Compounds and methods for blocking apoptosis and inducing autophagy
Follow on Funding and Exits
New Company/VC
Industry Sponsored Research
Nido Biosciences
$500,000,000